These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18591445)

  • 21. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are there long-term benefits in following stable heart failure patients in a heart failure clinic?
    Leetmaa TH; Villadsen H; Mikkelsen KV; Davidsen F; Haghfelt T; Videbaek L
    Scand Cardiovasc J; 2009 Jun; 43(3):158-62. PubMed ID: 19065446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure.
    Lupón J; González B; Santaeugenia S; Altimir S; Urrutia A; Más D; Díez C; Pascual T; Cano L; Valle V
    Rev Esp Cardiol; 2008 Aug; 61(8):835-42. PubMed ID: 18684366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter by Madias regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    Madias JE
    Circulation; 2009 Jul; 120(3):e21; author reply e22. PubMed ID: 19620522
    [No Abstract]   [Full Text] [Related]  

  • 26. The pathophysiology of acute heart failure--it is a lot about fluid accumulation.
    Metra M; Dei Cas L; Bristow MR
    Am Heart J; 2008 Jan; 155(1):1-5. PubMed ID: 18082481
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    De Ferrari GM; Verrier RL
    Circulation; 2009 Jul; 120(3):e20; author reply e22. PubMed ID: 19620521
    [No Abstract]   [Full Text] [Related]  

  • 29. Absence of exercise capacity improvement after exercise training program: a strong prognostic factor in patients with chronic heart failure.
    Tabet JY; Meurin P; Beauvais F; Weber H; Renaud N; Thabut G; Cohen-Solal A; Logeart D; Ben Driss A
    Circ Heart Fail; 2008 Nov; 1(4):220-6. PubMed ID: 19808295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter to the editor: Weekend versus weekday hospital admissions for acute heart failure.
    Refiker Ege M; Yilmaz N
    Int J Cardiol; 2011 Mar; 147(2):330. PubMed ID: 21277030
    [No Abstract]   [Full Text] [Related]  

  • 31. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
    [No Abstract]   [Full Text] [Related]  

  • 32. TEACH: Trial of Education And Compliance in Heart dysfunction chronic disease and heart failure (HF) as an increasing problem.
    Gwadry-Sridhar F; Guyatt G; O'Brien B; Arnold JM; Walter S; Vingilis E; MacKeigan L
    Contemp Clin Trials; 2008 Nov; 29(6):905-18. PubMed ID: 18703166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
    Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
    Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
    Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS
    Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors.
    Bai R; Di Biase L; Elayi C; Ching CK; Barrett C; Philipps K; Lim P; Patel D; Callahan T; Martin DO; Arruda M; Schweikert RA; Saliba WI; Wilkoff B; Natale A
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1259-65. PubMed ID: 18631272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of Holter monitoring in congestive heart failure.
    Cygankiewicz I; Zareba W; de Luna AB
    Cardiol J; 2008; 15(4):313-23. PubMed ID: 18698539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heart failure epidemiology in Apulia, Italy, from 2001-2006].
    Caldarola P; Cuonzo M; Troso F; Mazzone A; Doronzo F
    G Ital Cardiol (Rome); 2009 Mar; 10(3):135-9. PubMed ID: 19385307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
    Blair JE; Zannad F; Konstam MA; Cook T; Traver B; Burnett JC; Grinfeld L; Krasa H; Maggioni AP; Orlandi C; Swedberg K; Udelson JE; Zimmer C; Gheorghiade M;
    J Am Coll Cardiol; 2008 Nov; 52(20):1640-8. PubMed ID: 18992654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden cardiac death in China.
    Zhang S
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1159-62. PubMed ID: 19719492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.